Boehringer says H1 operating profit up 30-40 pct – Reuters
Boehringer says H1 operating profit up 30-40 pct Reuters Revenue from its blockbuster drug Spiriva, an inhalant against COPD, also known as smokers lung, increased 15 percent to 1.18 billion euros. ... Good First Six Months In 2009 For Boehringer Ingelheim ...PharmaLive.com (press release) BI: pig vaccine drives strong growth 28 Jul 2009PigProgress.net all 6 news articles » |